Viking Global Investors LP activity
Every position Andreas Halvorsen opened, added to, trimmed or closed between 2026 Q1 and 2026 Q2.
New
35
Add
18
Reduce
27
Exit
22
102 shown
| Ticker | Action | Δ weight | Detail | Period |
|---|---|---|---|---|
| RACE | New | 0% to 2.3% | $817M | Q1→Q2 |
| MSCI | New | 0% to 1.9% | $650M | Q1→Q2 |
| UNP | New | 0% to 1.6% | $557M | Q1→Q2 |
| DLR | New | 0% to 1.2% | $415M | Q1→Q2 |
| CCL | New | 0% to 1.2% | $409M | Q1→Q2 |
| CVS | New | 0% to 1.1% | $379M | Q1→Q2 |
| FDX | New | 0% to 1.0% | $357M | Q1→Q2 |
| MS | New | 0% to 0.97% | $339M | Q1→Q2 |
| QCOM | New | 0% to 0.80% | $280M | Q1→Q2 |
| APTV | New | 0% to 0.80% | $279M | Q1→Q2 |
| AVB | New | 0% to 0.72% | $253M | Q1→Q2 |
| SNOW | New | 0% to 0.70% | $244M | Q1→Q2 |
| EQH | New | 0% to 0.68% | $237M | Q1→Q2 |
| TTWO | New | 0% to 0.67% | $235M | Q1→Q2 |
| SPCX | New | 0% to 0.58% | $205M | Q1→Q2 |
| BCE | New | 0% to 0.51% | $181M | Q1→Q2 |
| USFD | New | 0% to 0.51% | $177M | Q1→Q2 |
| UBS | New | 0% to 0.34% | $121M | Q1→Q2 |
| BTSG | New | 0% to 0.32% | $113M | Q1→Q2 |
| NTRA | New | 0% to 0.30% | $106M | Q1→Q2 |
| DB | New | 0% to 0.24% | $85M | Q1→Q2 |
| CRBG | New | 0% to 0.22% | $77M | Q1→Q2 |
| SEDG | New | 0% to 0.18% | $64M | Q1→Q2 |
| BRKR | New | 0% to 0.15% | $54M | Q1→Q2 |
| CME | New | 0% to 0.10% | $34M | Q1→Q2 |
| TW | New | 0% to 0.09% | $31M | Q1→Q2 |
| INFQ | New | 0% to 0.08% | $27M | Q1→Q2 |
| ARTV | New | 0% to 0.07% | $25M | Q1→Q2 |
| QNT | New | 0% to 0.07% | $25M | Q1→Q2 |
| ALT | New | 0% to 0.06% | $20M | Q1→Q2 |
| FRVO | New | 0% to 0.06% | $22M | Q1→Q2 |
| TOL | New | 0% to 0.05% | $18M | Q1→Q2 |
| XE | New | 0% to 0.04% | $13M | Q1→Q2 |
| DPC | New | 0% to 0.04% | $15M | Q1→Q2 |
| Azul | New | 0% to 0.03% | $12M | Q1→Q2 |
| AAPL | Exit | 2.6% to 0% | $912M | Q1→Q2 |
| CSX | Exit | 2.1% to 0% | $767M | Q1→Q2 |
| GOOGL | Exit | 1.9% to 0% | $689M | Q1→Q2 |
| PNC | Exit | 1.8% to 0% | $630M | Q1→Q2 |
| TMUS | Exit | 1.7% to 0% | $623M | Q1→Q2 |
| HCA | Exit | 1.4% to 0% | $509M | Q1→Q2 |
| CLS | Exit | 1.3% to 0% | $466M | Q1→Q2 |
| CCL | Exit | 0.99% to 0% | $355M | Q1→Q2 |
| PGR | Exit | 0.90% to 0% | $320M | Q1→Q2 |
| AIG | Exit | 0.89% to 0% | $318M | Q1→Q2 |
| APG | Exit | 0.66% to 0% | $237M | Q1→Q2 |
| CBOE | Exit | 0.54% to 0% | $193M | Q1→Q2 |
| AJG | Exit | 0.44% to 0% | $158M | Q1→Q2 |
| LULU | Exit | 0.42% to 0% | $150M | Q1→Q2 |
| STLA | Exit | 0.31% to 0% | $112M | Q1→Q2 |
| CRWV | Exit | 0.30% to 0% | $108M | Q1→Q2 |
| WST | Exit | 0.29% to 0% | $105M | Q1→Q2 |
| EW | Exit | 0.25% to 0% | $88M | Q1→Q2 |
| RAL | Exit | 0.25% to 0% | $89M | Q1→Q2 |
| TWLO | Exit | 0.16% to 0% | $57M | Q1→Q2 |
| EQPT | Exit | 0.06% to 0% | $20M | Q1→Q2 |
| FPS | Exit | 0.05% to 0% | $19M | Q1→Q2 |
| AMZN | Add | 0.70% to 2.5% | +209.6% sh | Q1→Q2 |
| META | Add | 1.7% to 3.0% | +75.8% sh | Q1→Q2 |
| SHW | Add | 2.8% to 3.8% | +24.5% sh | Q1→Q2 |
| IBKR | Add | 0.26% to 1.2% | +246.5% sh | Q1→Q2 |
| V | Add | 5.4% to 6.3% | +1.0% sh | Q1→Q2 |
| WAT | Add | 1.1% to 1.8% | +32.3% sh | Q1→Q2 |
| APD | Add | 3.3% to 4.0% | +15.5% sh | Q1→Q2 |
| LII | Add | 2.0% to 2.6% | +1.2% sh | Q1→Q2 |
| JPM | Add | 2.2% to 2.7% | +7.2% sh | Q1→Q2 |
| TMO | Add | 2.3% to 2.8% | +16.2% sh | Q1→Q2 |
| HD | Add | 0.46% to 0.93% | +82.6% sh | Q1→Q2 |
| SE | Add | 1.1% to 1.6% | +19.7% sh | Q1→Q2 |
| MAA | Add | 1.6% to 2.0% | +5.1% sh | Q1→Q2 |
| BA | Add | 1.8% to 2.0% | +2.5% sh | Q1→Q2 |
| BMRN | Add | 1.1% to 1.2% | +7.9% sh | Q1→Q2 |
| CVNA | Add | 2.4% to 2.3% | +343.2% sh | Q1→Q2 |
| AON | Add | 0.98% to 1.1% | +5.9% sh | Q1→Q2 |
| FDX | Add | 1.9% to 1.9% | +11.4% sh | Q1→Q2 |
| TSLA | Reduce | 2.6% to 0.66% | −78.0% sh | Q1→Q2 |
| DIS | Reduce | 3.6% to 2.0% | −46.2% sh | Q1→Q2 |
| ICE | Reduce | 2.1% to 0.97% | −42.6% sh | Q1→Q2 |
| SCHW | Reduce | 3.9% to 2.8% | −27.5% sh | Q1→Q2 |
| MCD | Reduce | 3.2% to 2.2% | −22.0% sh | Q1→Q2 |
| MDLN | Reduce | 1.4% to 0.54% | −57.7% sh | Q1→Q2 |
| MSFT | Reduce | 2.4% to 1.6% | −36.8% sh | Q1→Q2 |
| GM | Reduce | 1.9% to 1.1% | −45.5% sh | Q1→Q2 |
| CB | Reduce | 1.2% to 0.37% | −70.9% sh | Q1→Q2 |
| ATI | Reduce | 1.4% to 0.65% | −65.4% sh | Q1→Q2 |
| COF | Reduce | 0.82% to 0.22% | −75.9% sh | Q1→Q2 |
| BBIO | Reduce | 2.5% to 2.1% | −16.0% sh | Q1→Q2 |
| HAS | Reduce | 0.98% to 0.73% | −16.9% sh | Q1→Q2 |
| MANE | Reduce | 0.30% to 0.55% | −7.6% sh | Q1→Q2 |
| RRX | Reduce | 1.7% to 1.4% | −33.1% sh | Q1→Q2 |
| RDDT | Reduce | 0.96% to 0.77% | −38.6% sh | Q1→Q2 |
| CPT | Reduce | 1.3% to 1.5% | −4.3% sh | Q1→Q2 |
| JCI | Reduce | 1.6% to 1.8% | −4.9% sh | Q1→Q2 |
| ROIV | Reduce | 0.52% to 0.63% | −5.7% sh | Q1→Q2 |
| AS | Reduce | 0.67% to 0.57% | −18.1% sh | Q1→Q2 |
| TSM | Reduce | 4.2% to 4.3% | −29.0% sh | Q1→Q2 |
| ORIC | Reduce | 0.21% to 0.16% | −12.0% sh | Q1→Q2 |
| ORKA | Reduce | 0.37% to 0.41% | −43.6% sh | Q1→Q2 |
| INBX | Reduce | 0.27% to 0.30% | −21.8% sh | Q1→Q2 |
| TRVI | Reduce | 0.11% to 0.08% | −51.7% sh | Q1→Q2 |
| DKS | Reduce | 0.70% to 0.72% | −12.5% sh | Q1→Q2 |
| FTV | Reduce | 3.5% to 3.5% | −11.3% sh | Q1→Q2 |